Cargando…
Dimeric MHC-peptides inserted into an immunoglobulin scaffold as new immunotherapeutic agents
The interactions of the T cell receptor (TCR) with cognate MHC-peptide and co-stimulatory molecules expressed at surface of antigen presenting cells (APC) leads to activation or tolerance of T cells. The development of molecular biological tools allowed for the preparation of soluble MHC-peptide mol...
Autores principales: | Goldberg, Burt, Bona, Constantin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918039/ https://www.ncbi.nlm.nih.gov/pubmed/21435177 http://dx.doi.org/10.1111/j.1582-4934.2011.01319.x |
Ejemplares similares
-
Immunotherapeutic Agents for Intratumoral Immunotherapy
por: Shyr, Chih-Rong, et al.
Publicado: (2023) -
LTX-315 – a promising novel antitumor peptide and immunotherapeutic agent
por: Zweytick, Dagmar
Publicado: (2019) -
Immunotherapeutic strategies in autoimmune uveitis
por: Papotto, Pedro Henrique, et al.
Publicado: (2014) -
Antimicrobial Peptides As Biologic and Immunotherapeutic Agents against Cancer: A Comprehensive Overview
por: Roudi, Raheleh, et al.
Publicado: (2017) -
Peptide-Based Immunotherapeutics and Vaccines
por: Reche, Pedro A., et al.
Publicado: (2014)